[MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions

Growing biopharmaceutical company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers.

Read more here.

The post [MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions appeared first on OurCrowd Blog.

OurCrowd Blog

[MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions

Israeli health company MeMed Diagnostics Ltd., which developed a test that can identify whether an infection was caused by a virus or bacteria thus significantly reducing the use of antibiotics for treatment, has received regulatory approval to put its rapid test, which can provide results within 15 minutes, on the Israeli and European market.

Read more here.

The post [MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions appeared first on OurCrowd.

OurCrowd